Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiac Catheterization II: Right Heart Catheterization

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bionic Nanocoating of Prosthetic Grafts Significantly Reduces Bacterial Growth.

ACS applied materials & interfaces·2024

Same author

Anticoagulation in LVAD recipients and thrombembolic complications: Where do we stand? Where are we going to?

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2024

Same author

Is Single LIMA-LAD Bypass Appropriate for OPCAB Training?

The Thoracic and cardiovascular surgeon·2024

Same author

Infection remediation after septic device extractions: analysis of three treatment strategies including a 1-year follow-up.

Frontiers in cardiovascular medicine·2024

Same author

Early outcome of endoscopic mitral valve surgery in elderly patients: a high-volume single center experience.

Frontiers in cardiovascular medicine·2023

Same author

Balloon-expandable transcatheter heart valves for treatment of aortic valve stenosis in patients with large aortic annuli: Evaluation of deployment balloon overfilling strategies.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2023

Search research articles

Related Experiment Video

Updated: May 13, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Isolated permanent right ventricular assistance using the HVAD continuous-flow pump.

Tobias Deuse¹, Johannes Schirmer, Mathias Kubik

¹University Heart Center Hamburg, Hamburg, Germany. t.deuse@uke.de

The Annals of Thoracic Surgery

|March 26, 2013

Summary

Acute right ventricular failure is rare. A HeartWare HVAD was successfully used for isolated right heart support in a patient with myocardial infarction, demonstrating a novel treatment option.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Experiment Videos

Last Updated: May 13, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Area of Science:

Cardiology
Cardiovascular Surgery
Biomedical Engineering

Background:

Acute isolated right ventricular (RV) failure secondary to myocardial infarction is uncommon.
Currently, no dedicated assist devices are approved for permanent isolated RV support.
Management of RV infarction often relies on supportive measures.

Observation:

A patient experienced extensive RV myocardial infarction due to iatrogenic right coronary artery dissection.
The HeartWare HVAD system was implanted for isolated RV mechanical support.

Findings:

The implantation was successful, providing effective isolated RV assistance.
The device seamlessly integrated with the pulmonary circulation without requiring system modifications.

Implications:

This case demonstrates the potential utility of existing ventricular assist devices for off-label isolated RV support.
Successful HVAD implantation offers a potential therapeutic option for rare cases of RV failure unresponsive to conventional treatments.